EUVIMEDEUVIMED entdecken
Crossref

Rational Development of NAMPT/PARP1 Dual Inhibitors Targeting NAD Metabolism for Breast Cancer Therapy

Jinwoo Park, Minji Kim, Seung Lee

Bulletin of Pioneering Researches of Medical and Clinical Science · 2025 · 5 (2) · 202-223

DOI: 10.51847/hc2kbdacqu ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulletin of Pioneering Researches of Medical and Clinical Science, 2025. Verfasst von Jinwoo Park und 2 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Park, J., Kim, M., & Lee, S. (2025). Rational Development of NAMPT/PARP1 Dual Inhibitors Targeting NAD Metabolism for Breast Cancer Therapy. Bulletin of Pioneering Researches of Medical and Clinical Science, 5(2), 202-223. https://doi.org/10.51847/hc2kbdacqu

Vancouver

Park J, Kim M, Lee S. Rational Development of NAMPT/PARP1 Dual Inhibitors Targeting NAD Metabolism for Breast Cancer Therapy. Bulletin of Pioneering Researches of Medical and Clinical Science. 2025;5(2):202-223. doi:10.51847/hc2kbdacqu

BibTeX
@article{Park2025,
  author = {Park, Jinwoo and Kim, Minji and Lee, Seung},
  title = {Rational Development of NAMPT/PARP1 Dual Inhibitors Targeting NAD Metabolism for Breast Cancer Therapy},
  journal = {Bulletin of Pioneering Researches of Medical and Clinical Science},
  year = {2025},
  volume = {5},
  number = {2},
  pages = {202--223},
  doi = {10.51847/hc2kbdacqu}
}
Kostenlos starten →